【Shimadzu Corporation】2026 Financial Results｜Sales of 560.7 billion yen (+4.0% YoY)

Performance Overview

Shimadzu Corporation recorded sales of 560.7 billion yen (YoY +4.0%) for the fiscal year ending March 2026, reaching a new all-time high. Each segment, including measurement instruments, medical devices, and aerospace equipment, performed steadily, with notable improvements in profit margins for medical and aerospace equipment. Both domestic and international sales increased, especially contributing from Europe and Asia. Net income rose significantly to 6.05 billion yen (+12.5%), strengthening the company’s financial position. Based on the medium-term management plan, the company continues to invest in healthcare and green sectors, promoting the development of new products utilizing AI and robotics, and expanding its business.

Future Outlook and Impact on Shareholders

Shimadzu Corporation forecasts sales of 575.0 billion yen (+2.5%) and net income of 5.5 billion yen (-9.1%) for the fiscal year ending March 2027. The company plans to further strengthen overseas expansion and new product launches, aiming for a stable revenue base through recurring business models and AI technology integration. The dividend is expected to be 69 yen (forecast annually), maintaining shareholder returns. Despite potential risks from geopolitical issues and raw material cost increases, the company is committed to maintaining financial soundness and pursuing sustainable growth.